BRUSSELS, Belgium, Feb. 1, 2016 -- Delhaize Group NV/SA ("Delhaize") and Koninklijke Ahold N.V. ("Ahold") today announced that they have respectively called Extraordinary General Meetings ("EGM"), to be held on March 14, 2016, at which their respective shareholders will consider and vote on proposals to approve the intended merger between Delhaize and Ahold.
Delhaize's EGM will be held at the Proximus Lounge, rue Stroobantsstraat 51 in 1140 Brussels, Belgium on March 14, 2016 at 2:00 p.m. (CET). Ahold's EGM will be held at the Amsterdam Rai Convention Center on March 14, 2016 at 2:00 p.m. (CET).
Delhaize and Ahold have posted their respective EGM convocation documents and related materials on their respective websites at www.delhaizegroup.com and www.ahold.com.
The right of Delhaize shareholders to attend and to vote their shares at the Delhaize EGM is subject to the registration of such shares by 11:59 p.m. (CET) on the record date, which is Monday, February 29, 2016.
Delhaize and Ahold also announced today that the registration statement on Form F-4 filed by Ahold ("Registration Statement"), which includes a prospectus ("U.S. Prospectus"), was declared effective by the U.S. Securities and Exchange Commission ("SEC") on January 28, 2016. The Registration Statement will be available through the website maintained by the SEC at www.sec.gov, and the U.S. Prospectus has been posted by Delhaize and Ahold on their respective websites at www.delhaizegroup.com and www.ahold.com, as well as at www.adcombined.com.
Delhaize and Ahold announced as well today that the Dutch Authority for the Financial Markets (Stichting Autoriteit Financiële Markten or "AFM") had approved a prospectus registered with the AFM by Ahold ("EU Prospectus"). The EU Prospectus has been passported into Belgium. The EU Prospectus is required in connection with the admission to listing and trading on Euronext Amsterdam of the Ahold ordinary shares to be issued as part of the intended merger, and in connection with the admission to listing and trading on Euronext Brussels of the Ahold ordinary shares. The EU Prospectus has been posted by Delhaize and Ahold on their respective websites at www.delhaizegroup.com and www.ahold.com, as well as at www.adcombined.com.
On June 24, 2015, Delhaize and Ahold announced their intention to merge, creating an international retailer with a portfolio of strong, trusted local brands and more than 375,000 associates serving more than 50 million customers each week in the United States and Europe.
Ahold Delhaize will offer enhanced choice and value for customers, provide more compelling opportunities for associates and contribute even more to the local communities it serves.
The transaction is expected to be completed in mid-2016, following associate consultation procedures, shareholder approval and regulatory clearances.
» Delhaize Group
Delhaize Group is a Belgian international food retailer present in seven countries on three continents. At the end of 2015, Delhaize Group's sales network consisted of 3 512 stores. In 2015, Delhaize Group posted €24.4 billion ($27.1 billion) in revenues. In 2014, Delhaize Group posted €89 million ($118 million) in net profit (Group share). At the end of 2014, Delhaize Group employed approximately 150 000 people. Delhaize Group's stock islisted on NYSE Euronext Brussels (DELB) and the New York Stock Exchange (DEG).
This press release is available in English, French and Dutch. You can also find it on the website http://www.delhaizegroup.com. Questions can be sent to [email protected].
» Contacts
Investor Relations: + 32 2 412 2151
Media Relations: + 32 2 412 8669
Press release in PDF http://hugin.info/133961/R/1982435/726432.PDF
HUG#1982435


Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Samsung Electronics Shares Jump on HBM4 Mass Production Report
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Washington Post Publisher Will Lewis Steps Down After Layoffs
Anta Sports Expands Global Footprint With Strategic Puma Stake
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 



